Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor

Publisher： Karger

E-ISSN： 1663-2826|78|1|54-58

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.78, Iss.1, 2012-07, pp. : 54-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Mechanisms Involved in Glucagon-Like Peptide-1 (7–36) Amide Action on the Rat Hypothalamo-Neurohypophysial System

By  

Neuroendocrinology, Vol. 77, Iss. 2, 2003-03 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2012-12 ,pp. : 300-308

Karger

Access to resources Recommend Favorite

Effects of Glucagon-Like Peptide 1 (7–36 Amide) on Glucose Kinetics during Somatostatin-Induced Suppression of Insulin Secretion in Healthy Men

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 5, 1998-04 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Idiopathic Intracranial Hypertension and Obesity

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 4, 2014-03 ,pp. : 217-225

Karger

Access to resources Recommend Favorite